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Abstract This study evaluated the expression of Wbronec-
tin, tenascin and type I collagen in ameloblastomas and
adenomatoid odontogenic tumors (AOTs) aiming to con-
tribute with the comprehension of the diVerences in the bio-
logical behavior of these tumors. Immunohistochemical
technique was performed in 20 cases of ameloblastoma (16
solid and 4 desmoplastic) and in 10 cases of AOT. All
tumors presented moderate Wbronectin expression in the
stroma. Solid ameloblastomas showed intense expression
of Wbronectin at the epithelial–mesenchymal interface,
whereas desmoplastic ameloblastomas revealed no immu-
noexpression of Wbronectin at this site. Ameloblastomas
presented stronger immunoreactivity to tenascin than
AOTs, especially at the epithelial–mesenchymal interface.
AOTs and desmoplastic ameloblastomas showed intense
labeling for type I collagen. The patterns of expression of
the proteins studied agree with the locally more invasive
behavior of ameloblastomas in comparison to AOTs. Our
results might suggest a less invasive behavior of desmo-
plastic ameloblastoma in comparison to solid ameloblas-
toma.
Keywords Ameloblastoma · Adenomatoid odontogenic 
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Introduction
Ameloblastoma is a benign epithelial odontogenic tumor,
with mature Wbrous stroma without odontogenic ectomes-
enchyme, which has been extensively studied due to its
locally inWltrative behavior [1]. Adenomatoid odontogenic
tumor (AOT), although being composed by odontogenic
epithelium embedded in a mature connective tissue stroma,
commonly shows an indolent evolution [2, 3].
Recently, ameloblastomas have been classiWed in four
distinct subtypes: solid, unicystic, peripheral, and desmo-
plastic [1]. In solid ameloblastomas, the neoplastic cells can
be arranged in diVerent histopathological patterns, such as:
follicular, plexiform, acanthomatous, granular cell, and
basal cell [1]. This histological diversity can be observed
between diVerent cases but more than one morphological
pattern can also be present within the same lesion [4]. In
desmoplastic ameloblastomas, the stromal component domi-
nates, compressing the islands of odontogenic epithelium,
which are irregular in shape with a pointed, stellate appear-
ance [1]. Ameloblastomas presenting both desmoplastic and
other conventional histological patterns have been termed as
hybrid lesions [1, 5]. In contrast, AOT show peculiar and
frequently constant, histological characteristics [2].
In view of their intriguing biological behavior, amelobl-
astomas have been the subject of numerous studies that
employed diVerent methodologies. Most investigations
have focused on the characteristics of the epithelial compo-
nent that constitutes the tumor parenchyma [6–9] while few
studies have analyzed the properties of the extracellular
matrix (ECM), which constitutes the tumor stroma [10–13].
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motes cell adhesion and migration, and serves as a storage
site for growth factors, thus inXuencing cell growth, mor-
phology, and diVerentiation [14–16]. Based on these con-
siderations, the objective of the present study was to
analyze the expression of the ECM proteins Wbronectin,
tenascin and type I collagen in order to obtain data that,
together with those obtained in studies on the diVerentiation
and proliferation pattern of parenchymatous cells from
ameloblastomas and AOT, might contribute to a better
understanding of the biological behavior of these tumors.
Materials and methods
The present sample consisted of 20 cases of ameloblastoma
(16 solid and 4 desmoplastic) and 10 AOT randomly
selected from the Wles of the Anatomical Pathology Ser-
vice, Discipline of Oral Pathology, Federal University of
Rio Grande do Norte, Brazil. The paraYn-embedded speci-
mens were collected and evaluated in accordance with all
ethical and legal requirements.
ParaYn-embedded material was cut into 3-m thick
sections and stained by immunohistochemistry. BrieXy,
specimens were deparaYnized, hydrated in a decreasing
ethanol sequence and formalin pigment was removed with
10% ammonium hydroxide in 95° ethanol. For tenascin
and Wbronectin, prior to incubation with primary antibod-
ies, the samples were treated with 0.4 and 1% pepsin,
respectively, at 37°C for 60 min. For type I collagen,
specimens were treated with citric acid in a steamer for
5 min. Endogenous peroxidase was blocked by the addi-
tion of methanol–hydrogen peroxide solution. The speci-
mens were then incubated with the following primary
antibodies: anti-tenascin (clone TN2, Dako A/S, Glostrup,
Denmark; diluted 1:50, overnight at 4°C), anti-Wbronectin
(clone A 0245, Dako A/S; diluted 1:600, for 120 min at
room temperature), and anti-type I collagen (clone NCL-
COLL-Ip, Novocastra Laboratories; diluted 1:40, for
60 min at room temperature). The material was immersed
in Tris buVer, pH 7.4, between the reactions steps. The
specimens were then incubated with the second antibody
and the streptavidin–biotin complex (SABC, Dako) for
30 min at room temperature to bind the primary antibod-
ies. Peroxidase activity was visualized by immersing
tissue sections in diaminobenzidine (D5637; Sigma Chemical,
St. Louis, MO, USA). Finally, tissue sections were coun-
terstained with Mayer hematoxylin and coverslipped.
Positive controls for tenascin and Wbronectin were
sections of normal oral mucosa. Positive control for type I
collagen were sections of human placenta. An irrelevant,
isotype-matched antibody was used as a negative control
instead of primary antibodies.
After the immunohistochemical treatment, tissue sec-
tions were analyzed by light microscopy. The immunoreac-
tivity was evaluated in terms of intensity and pattern of
labeling. The distribution of these proteins was evaluated in
tumor stroma, epithelial–mesenchymal interface and tumor
cells. Comparisons were performed between ameloblasto-
mas and AOT, as well as between diVerent histopatholo-
gical patterns of ameloblastoma.
Results
In all ameloblastomas, morphological analysis disclosed
the existence of more than one histological pattern. Solid
ameloblastomas represented 16 cases and revealed mainly
follicular and plexiform areas. In four cases, areas of des-
moplastic ameloblastoma were associated to other histolog-
ical patterns, representing hybrid lesions. In all specimens
of AOT, morphological analysis revealed variably sized
nodules of cuboidal and columnar cells forming nests or
rosette-like structures within a scarce stroma of connective
tissue. Deposits of eosinophilic amorphous material were
observed in the center of rosette-like structures. In addition,
all cases presented a variable number of duct-like structures
lined by a single role of columnar epithelial cells.
Fibronectin
All cases of solid and desmoplastic ameloblastoma exhib-
ited Wbronectin immunoexpression throughout the tumor
stroma, which was mainly diVuse, Wbrillar, and with moder-
ate intensity (Table 1). At the epithelial–mesenchymal
interface, solid ameloblastomas showed an intense, linear,
and discontinuous expression of this protein (Fig. 1a). Des-
moplastic ameloblastomas showed no expression of Wbro-
nectin at the epithelial–mesenchymal interface (Fig. 1b).
Follicular areas of solid ameloblastomas revealed focal
expression of Wbronectin within epithelial tumor nests, both
in areas resembling the stellate reticulum and in cells adja-
cent to foci of cystic degeneration (Fig. 1c).
In all cases of AOT, moderate to intense Wbronectin
expression was found scattered throughout the stroma
(Table 1). Intense, linear and discontinuous labeling was
observed at the epithelial–mesenchymal interface (Fig. 2a).
Only few cases showed sparse foci of epithelial cell labeling.
Tenascin
Tenascin immunoexpression was characterized by a moder-
ate to intense, diVuse and heterogeneous labeling in the
stroma of all ameloblastomas (Table 2). Labeling was
mainly observed adjacent to tumor nests, and was markedly
intensiWed at the epithelial–mesenchymal interface123
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enlarged foci (Fig. 1d, e). On the other hand, tenascin
expression showed an amorphous and homogenous distri-
bution in areas of stromal degeneration in plexiform areas
of solid ameloblastomas. Follicular areas of solid amelobl-
astomas showed signiWcant expression of tenascin within
epithelial islands in areas resembling stellate reticulum and
with cystic degeneration (Fig. 1f).
Analysis of the expression of tenascin in the stroma of
AOT disclosed a variable intensity (Table 2; Fig. 2b). Focal
areas of marked immunolabeling of this protein were
observed close to the tumor parenchyma.
Type I collagen
Moderate to intense immunolabeling for type I collagen
was observed in the stroma of all solid and desmoplastic
ameloblastomas (Table 3). In comparison with solid ame-
loblastomas, desmoplastic ameloblastomas exhibited higher
intensity of expression of type I collagen, always with a
Fig. 1 Immunohistochemical 
staining of ameloblastomas. 
a Intense and discontinuous 
expression of Wbronectin at the 
epithelial–mesenchymal inter-
face and moderate immunoreac-
tion in the tumor stroma of solid 
ameloblastoma (SABC 200£). 
b Moderate Wbrillar positivity of 
Wbronectin throughout the tumor 
stroma of desmoplastic amelo-
blastoma (SABC 200£). 
c Expression of Wbronectin in 
epithelial tumor nest of solid 
ameloblastoma (SABC 400£). 
d Marked linear immunoexpres-
sion of tenascin at the epithelial–
mesenchymal interface of solid 
ameloblastoma (SABC 200£). 
e Remarkable immunoreaction 
of tenascin at the epithelial–
mesenchymal interface of 
desmoplastic ameloblastoma 
(SABC 200£). f Tenascin 
expression observed in epithelial 
islands and in the basement 
membrane zone of solid 
ameloblastoma (SABC 400£). 
g Fibrillar immunolabeling of 
type I collagen observed in the 
neoplastic stroma of solid 
ameloblastoma (SABC 200£). 
h Intense positivity of type I 
collagen in the tumor stroma of 
desmoplastic ameloblastoma 
(SABC 200£)123
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loblastomas revealed an occasional immunoreactivity for
type I collagen, particularly in foci of stromal degeneration.
AOT showed type I collagen immunoreactivity in all
cases, mainly with an intense and Wbrillar to Wbro-reticular
labeling throughout the tumor stroma (Table 3). Some
specimens exhibited irregular accumulation of type I colla-
gen between epithelial cells and inside some duct-like
structures (Fig. 2c, d).
Discussion
In order to elucidate the mechanisms beneath the locally
aggressive behavior of ameloblastomas, many studies have
been performed, most of them aimed at the characterization
of the cell cycle and pattern of diVerentiation of tumor par-
enchymatous cells [7–9]. Based on the assumption that both
in physiologic and pathological conditions, cell growth and
diVerentiation are inXuenced by cell–ECM interactions the
study of the characteristics of ECM might be important to
understand these relationships in tumor development. Previ-
ous studies have indicated a fundamental role for ECM in
the development of neoplasms [13, 16–18].
Recent studies have shown that the ECM does not only
act passively as a support for cells, but also provides infor-
mation to these cells modifying their behavior, an event
that might be responsible for tumorigenesis [16–20].
Among the ECM components, some proteins are important
due to their regulatory or structural functions. Fibronectin
is a glycoprotein, which possesses an important signaling
function in cell adhesion and migration [5, 17, 20–23].
Table 1 Pattern of distribution and intensity of the immunoreactivity for Wbronectin in tumor stroma, epithelial–mesenchymal interface and
epithelial cells
Specimen Tumor stroma Epithelial–mesenchymal interface Epithelial cells
Pattern Intensity Pattern Intensity
Solid ameloblastoma (n = 16)
Follicular areas Fibrillar Moderate Linear and discontinuous Moderate to intense Focal positivity
Plexiform areas Fibrillar to 
Wbro-reticular
Moderate Linear and discontinuous Intense No staining
Basal cell areas Fibrillar Intense Linear and discontinuous Intense No staining
Desmoplastic 
ameloblastoma (n = 4)
Fibrillar Moderate No staining No staining No staining
Adenomatoid odontogenic 





Linear and discontinuous Intense Focal positivity
Fig. 2 Immunohistochemical 
staining of adenomatoid odonto-
genic tumors. a Immunolabeling 
of Wbronectin throughout the 
tumor stroma and marked immu-
noexpression at the epithelial–
mesenchymal interface (SABC 
200£). b Focal areas of marked 
Wbrillar immunolabeling of ten-
ascin in the stroma and evident 
immunoreaction in blood vessels 
wall (SABC 200£). c Intense 
and diVuse labeling of type I col-
lagen observed in the stroma and 
irregular accumulation between 
epithelial cells (SABC 200£). 
d Immunoexpression of type I 
collagen inside duct-like struc-
ture (SABC 200£)123
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time points and sites during embryogenesis. The highest
expression of tenascin is observed in unstable environments
such as during cell migration, in active areas of epithelial–
mesenchymal interactions, and in neoplastic stroma [14, 16,
18, 24]. Type I collagen is found throughout the connective
tissue and is one of the most abundant components of the
interstitial ECM [5, 23, 25], being highly resistant to
proteases due to its unique supercoiled triple helix structure
[26–28].
In the present study, the expression and distribution of
Wbronectin, tenascin, and type I collagen were analyzed in
ameloblastomas and AOT. Few investigations about the
ECM composition in odontogenic cysts and tumors have
been carried out [10–13, 29, 30].
Our Wndings reveal a wide distribution of Wbronectin in
the stroma of solid ameloblastomas, desmoplastic amelobl-
astomas, and AOT. In AOT, a heterogeneous expression,
with moderate intensity, was found scattered throughout the
tumor stroma and in areas close to the parenchyma. Murata
et al. [30] and Poomsawat et al. [13] suggested that AOT
cells, like pre-ameloblasts, are able to synthesize ECM pro-
teins due to the presence of Wbronectin inside the luminal
spaces of duct-like structures. Although this latter Wnding
could not be veriWed in the present study, the focal positiv-
ity for Wbronectin in epithelial cells of AOT conWrms the
capacity of these cells to synthesize this glycoprotein [13,
29]. Further analysis of our results showed that Wbronectin
expression is more intense at the epithelial–mesenchymal
interface of both solid ameloblastomas and AOT, showing
a linear and discontinuous distribution in most cases, a fact
also reported by Heikinheimo et al. [28].
A strong immunoreactivity to Wbronectin was observed
at the epithelial–mesenchymal interface of plexiform and
follicular areas of solid ameloblastomas. Such distribu-
tion of Wbronectin is probably related to the characteris-
tics of the cells at the periphery of tumor cords and nests,
which exhibit a tall columnar morphology, palisaded
arrangement, and inverted nuclear polarization. In general,
these cells present hyperchromatic nuclei and vacuolated
cytoplasm resembling pre-ameloblasts. Desmoplastic
ameloblastomas did not show expression of Wbronectin at
the basement membrane region, a fact that might be
related to the lack of similarities between pre-ameloblasts
and the peripheral epithelial cells of desmoplastic ame-
loblastomas [5, 31].
Table 2 Pattern of distribution and intensity of the immunoreactivity for tenascin in tumor stroma, epithelial–mesenchymal interface and epithe-
lial cells
Specimen Tumor stroma Epithelial–mesenchymal interface Epithelial cells
Pattern Intensity Pattern Intensity
Solid ameloblastoma (n = 16)
Follicular areas Fibrillar to 
Wbro-reticular
Moderate Linear and discontinuous Moderate to intense Positivity
Plexiform areas Fibrillar to 
Wbro-reticular
Weak to moderate Linear and discontinuous Weak to intense No staining
Basal cell areas Fibrillar Moderate to intense Linear and discontinuous Moderate to intense No staining
Desmoplastic 
ameloblastoma (n = 4)
Fibrillar Intense Linear and discontinuous Moderate Positivity
Adenomatoid odontogenic 
tumor (n = 10)
Fibrillar to 
Wbro-reticular
Weak to moderate Linear and discontinuous Weak Focal positivity
Table 3 Distribution of cases 
according to the pattern and 
intensity of the 
immunoreactivity for type I 
collagen in tumor stroma
Specimen Tumor stroma Epithelial cells
Pattern Intensity
Solid ameloblastoma (n = 16)
Follicular areas Fibrillar to 
Wbro-reticular
Moderate to intense No staining
Plexiform areas Fibrillar to 
Wbro-reticular
Moderate to intense No staining
Basal cell areas Fibrillar Moderate to intense No staining
Desmoplastic 
ameloblastoma (n = 4)
Fibrillar Intense No staining
Adenomatoid odontogenic 
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51 integrin at the epithelial–mesenchymal interface of all
histological subtypes of ameloblastoma. Integrin 51 is
the classic receptor for Wbronectin [17, 24]. The binding of
integrin 51 to Wbronectin plays a crucial role in the
migration of neoplastic cells and is capable of increasing
the expression and secretion of matrix metalloproteinases
[32, 33]. Therefore, 51 integrin has been implicated as an
important molecule for the local invasiveness of ameloblas-
toma [32].
In the present study, no expression of Wbronectin was
observed in the basement membrane region of desmoplastic
ameloblastomas. Despite the classiWcation of desmoplastic
ameloblastoma as a distinct subtype of ameloblastoma [1],
the biological behavior of this variant is not fully under-
stood [34]. Due to the absence of Wbronectin in the base-
ment membrane region of desmoplastic ameloblastoma,
integrin 51 cannot bind to this glycoprotein. Therefore,
migration of neoplastic cells and expression and secretion
of matrix metalloproteinases would be aVected in this sub-
type of ameloblastoma.
Tenascin was frequently detected in the stroma of ame-
loblastomas, particularly in areas close to the epithelial–
mesenchymal interface. These results suggest a possible
role for this protein in the interactions between tumor cells
and adjacent stroma [11]. In agreement with the reports of
Murata et al. [30], AOT showed tenascin expression in the
tumor stroma, with a strong perivascular labeling. How-
ever, in the present study, while the expression of this pro-
tein was intense in most cases of ameloblastoma, in AOT
this expression was weaker, with large areas showing no
labeling at all.
Both types of tumor showed linear and discontinuous
expression of tenascin in the basement membrane region
which, however, was more expressive in solid and desmo-
plastic ameloblastomas, in contrast to the Wndings of
Mori et al. [11]. The high expression of tenascin in ame-
loblastomas, especially close to the epithelial–mesenchymal
interface, might suggest a strong interaction between paren-
chyma and stroma in order to create a microenvironment
permissive to the high proliferative activity and invasive
capacity of tumor cells. This suggestion is based on the
already established role of tenascin in epithelial–mesenchymal
interactions during embryogenesis and development of
several pathological processes [14, 16, 18, 24].
The present results also showed an intense immunolabel-
ing for tenascin within epithelial islands of solid ameloblas-
tomas, particularly in areas resembling stellate reticulum and
in areas of cystic degeneration. These Wndings raise the pos-
sibility that this glycoprotein would be associated with the
initial formation of cystic spaces or cavitations frequently
observed inside tumor nests of follicular areas of solid ame-
loblastomas [11]. We believe that the sum of the growth
potential of these microcysts might contribute to the elevated
growth potential and the consequent markedly aggressive
nature reported for most multicystic ameloblastomas.
With respect to the expression of type I collagen, both
ameloblastomas and AOT disclosed a moderate to intense,
diVuse distribution of this protein in the tumor stroma. In
comparison with solid ameloblastomas, AOT showed a more
intense type I collagen labeling, probably due to the presence
of a dense and mature Wbrous capsule that corresponds to a
structurally, well-organized and stable connective tissue [23,
35]. The less expressive immunolabeling for type I collagen
in solid ameloblastomas could be related to the presence of
tumor cell-induced metalloproteinases [22] in tumor stroma,
which can reduce the amount of this protein.
The distribution of type I collagen in the stroma of des-
moplastic ameloblastomas was similar to that veriWed in
AOT, and probably reXects the greater collagenization of
these tumors [5]. Takata et al. [36] veriWed a high expres-
sion of transforming growth factor beta (TGF-) in desmo-
plastic ameloblastomas. TGF- stimulates various cells,
including Wbroblasts, to synthesize ECM, such as collagen,
Wbronectin, and proteoglycans [36]. Therefore, TGF- may
be important for desmoplastic matrix formation [36].
The analysis of the immunoexpression of type I collagen
and Wbronectin disclosed a distinct composition of the
ECM in desmoplastic ameloblastomas. Taken together, our
results might suggest a less invasive behavior of desmo-
plastic ameloblastomas in comparison to solid ameloblasto-
mas. In view of the few number of hybrid lesions in our
research and the absence of tumors composed only by the
desmoplastic pattern, further studies comparing desmoplas-
tic ameloblastomas, solid ameloblastomas, and hybrid
lesions are necessary in order to clarify the existence of a
diVerent biological behavior between these lesions.
Immunoexpression of type I collagen in AOT was also
observed in focal areas inside some duct-like structures, or
in the form of irregular aggregates permeating epithelial
cells organized in solid nests or whirls. According to
Murata et al. [30] and based on various experiments, the
diVerent types of ECM associated with AOT, either as
luminal content of duct-like structures or in the form of
hyaline droplets, consist of various forms of matrix con-
taining collagen Wbrils and their degradation products.
In summary, the variations observed in the immunoexpres-
sion of the proteins studied suggest a more locally invasive
behavior of ameloblastomas compared to AOT. Moreover,
our results might suggest a less invasive behavior in desmo-
plastic ameloblastoma. The present study demonstrated the
expression of Wbronectin, tenascin and type I collagen in ame-
loblastomas and AOT, but further investigations are necessary
to identify other ECM components involved in the diVerent
cellular mechanisms determining the development of tumors
and thus inXuencing their biological behavior.123
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